BALTIMORE--(BUSINESS WIRE)--Sept. 8, 2006--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas will report its financial results for the second quarter ended June 30, 2006, after the close of trading on the NASDAQ Global Market on Tuesday September 12, 2006. C. Randal Mills, Ph.D., President and Chief Executive Officer, and Cary J. Claiborne, Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Wednesday, September 13, 2006, at 8:00 a.m. EDT. To access the live webcast, please log on to the company's website at www.Osiris.com and go to the Investor Relations section. Alternatively, callers may participate in the conference call by dialing 800-819-9193 (U.S. participants) or 913-981-4911 (international participants).
